Houston Methodist Partners with CEPI and International Scientific Institutions to Advance First AI-Designed mRNA Vaccine against Deadly Tick-Borne Disease

0
156
Houston Methodist Research Institute is collaborating with the Coalition for Epidemic Preparedness Innovations and leading scientific institutions in the Republic of Korea to develop what could become the world’s first mRNA vaccine against severe fever with thrombocytopenia syndrome, a tick-borne viral disease associated with this condition.
[Houston Methodist Research Institute]
Press Release